Article Text

Download PDFPDF
General medicine
Optimal anticoagulant treatment of cancer-associated venous thromboembolism remains unclear

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors HAS wrote the manuscript and was solely responsible for concept and design, critical revision of the intellectual content and final approval.

  • Competing interests HAS: consultancy (Agios), outside of the topic of the submitted work.

  • Patient consent Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.